PL376607A1 - Application of antagonists oxytocin and/or vasopressin - Google Patents

Application of antagonists oxytocin and/or vasopressin

Info

Publication number: PL376607A1
Authority: PL; Poland
Prior art keywords: oxytocin; vasopressin; antagonists; application; antagonists oxytocin
Prior art date: 2005-08-12

Application number

PL376607A

Other languages

Polish (pl)

Inventor

Waldemar Kuczyński

Piotr Pierzyński

Original Assignee

Waldemar Kuczyński

Piotr Pierzyński

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-08-12

Filing date

2005-08-12

Publication date

2007-02-19

2005-08-12 Application filed by Waldemar Kuczyński, Piotr Pierzyński filed Critical Waldemar Kuczyński

2005-08-12 Priority to PL376607A priority Critical patent/PL376607A1/en

2006-05-10 Priority to DE602006021736T priority patent/DE602006021736D1/en

2006-05-10 Priority to ES06747719T priority patent/ES2366130T3/en

2006-05-10 Priority to MX2007014022A priority patent/MX2007014022A/en

2006-05-10 Priority to SI200631039T priority patent/SI1879572T1/en

2006-05-10 Priority to PCT/PL2006/000029 priority patent/WO2006121362A2/en

2006-05-10 Priority to PT06747719T priority patent/PT1879572E/en

2006-05-10 Priority to DK06747719.0T priority patent/DK1879572T3/en

2006-05-10 Priority to EP06747719A priority patent/EP1879572B1/en

2006-05-10 Priority to JP2008511075A priority patent/JP4762308B2/en

2006-05-10 Priority to AT06747719T priority patent/ATE507830T1/en

2006-05-10 Priority to PL06747719T priority patent/PL1879572T3/en

2006-05-10 Priority to CA2605923A priority patent/CA2605923C/en

2006-05-10 Priority to AU2006244693A priority patent/AU2006244693B2/en

2006-05-10 Priority to NZ562409A priority patent/NZ562409A/en

2006-05-10 Priority to CN2006800568367A priority patent/CN101646436B/en

2006-05-10 Priority to KR1020077025706A priority patent/KR100985449B1/en

2006-05-10 Priority to US11/914,049 priority patent/US20080318847A1/en

2006-05-10 Priority to RU2007140702/15A priority patent/RU2385735C2/en

2007-02-19 Publication of PL376607A1 publication Critical patent/PL376607A1/en

2007-10-11 Priority to IL186595A priority patent/IL186595A/en

2007-12-10 Priority to NO20076328A priority patent/NO340956B1/en

Links

101800000989 Oxytocin Proteins 0.000 title 1
XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 title 1
102100031951 Oxytocin-neurophysin 1 Human genes 0.000 title 1
GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 title 1
108010004977 Vasopressins Proteins 0.000 title 1
102000002852 Vasopressins Human genes 0.000 title 1
239000005557 antagonist Substances 0.000 title 1
KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 title 1
XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 title 1
229960001723 oxytocin Drugs 0.000 title 1
229960003726 vasopressin Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)

PL376607A 2005-05-10 2005-08-12 Application of antagonists oxytocin and/or vasopressin PL376607A1 (en)

Priority Applications (21)

Application Number	Priority Date	Filing Date	Title
PL376607A PL376607A1 (en)	2005-08-12	2005-08-12	Application of antagonists oxytocin and/or vasopressin
JP2008511075A JP4762308B2 (en)	2005-05-10	2006-05-10	Use of oxytocin and / or vasopressin antagonists in assisted reproduction
CA2605923A CA2605923C (en)	2005-05-10	2006-05-10	Use of antagonists of oxytocin and/or vasopressin
MX2007014022A MX2007014022A (en)	2005-05-10	2006-05-10	Use of antagonists of oxytocin and/or vasopressin in assisted reproduction.
SI200631039T SI1879572T1 (en)	2005-05-10	2006-05-10	Use of antagonists of oxytocin and/or vasopressin in assisted reproduction
PCT/PL2006/000029 WO2006121362A2 (en)	2005-05-10	2006-05-10	Use of antagonists of oxytocin and/or vasopressin in assisted reproduction
PT06747719T PT1879572E (en)	2005-05-10	2006-05-10	Use of antagonists of oxytocin and/or vasopressin in assisted reproduction
DK06747719.0T DK1879572T3 (en)	2005-05-10	2006-05-10	Use of antagonists of oxytocin and / or vasopressin in artificial insemination
EP06747719A EP1879572B1 (en)	2005-05-10	2006-05-10	Use of antagonists of oxytocin and/or vasopressin in assisted reproduction
DE602006021736T DE602006021736D1 (en)	2005-05-10	2006-05-10	USE OF ANTAGONISTS OF OXYTOCIN AND / OR VASOPRESSIN IN ASSISTED REPRODUCTION
AT06747719T ATE507830T1 (en)	2005-05-10	2006-05-10	USE OF ANTAGONISTS OF OXYTOCIN AND/OR VASOPRESSIN IN ASSISTED REPRODUCTION
PL06747719T PL1879572T3 (en)	2005-05-10	2006-05-10	Use of antagonists of oxytocin and/or vasopressin in assisted reproduction
ES06747719T ES2366130T3 (en)	2005-05-10	2006-05-10	USE OF OXYCHOCINE AND / OR VASOPRESINE ANTAGONISTS IN ASSISTED REPRODUCTION.
AU2006244693A AU2006244693B2 (en)	2005-05-10	2006-05-10	Use of antagonists of oxytocin and/or vasopressin in assisted reproduction
NZ562409A NZ562409A (en)	2005-05-10	2006-05-10	Use of barusiban in assisted reproduction
CN2006800568367A CN101646436B (en)	2005-05-10	2006-05-10	Use of antagonists of oxytocin and/or vasopressin in assisted reproductive technology
KR1020077025706A KR100985449B1 (en)	2005-05-10	2006-05-10	Uses of Oxytoxins and / or Vasopressin Antagonists
US11/914,049 US20080318847A1 (en)	2005-05-10	2006-05-10	Use of Antagonist of Oxytocin and/or Vasopressin in Assisted Reproduction
RU2007140702/15A RU2385735C2 (en)	2005-05-10	2006-05-10	Application of oxytocin antagonists in assisted reproduction
IL186595A IL186595A (en)	2005-05-10	2007-10-11	Use of barusiban for the preparation of medicaments for an improved uterine receptivity in assisted reproduction
NO20076328A NO340956B1 (en)	2005-05-10	2007-12-10	Use of antagonists for oxytocin and / or vasopressin

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PL376607A PL376607A1 (en)	2005-08-12	2005-08-12	Application of antagonists oxytocin and/or vasopressin

Publications (1)

Publication Number	Publication Date
PL376607A1 true PL376607A1 (en)	2007-02-19

Family

ID=43013708

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL376607A PL376607A1 (en)	2005-05-10	2005-08-12	Application of antagonists oxytocin and/or vasopressin

Country Status (1)

Country	Link
PL (1)	PL376607A1 (en)

2005
- 2005-08-12 PL PL376607A patent/PL376607A1/en not_active Application Discontinuation

Legal Events

Date	Code	Title	Description
2013-01-31	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
IL185343A0 (en)	2008-02-09	2-(4-oxo-4h-quinazolin-3-yl)acetamides and their use as vasopressin v3 antagonists
EP1952334A4 (en)	2011-06-08	Detection of intra-firm matching and response thereto
PL2027096T3 (en)	2012-10-31	Substituted arylimidaz0l0ne and triaz0l0ne as inhibitors of vasopressin receptors
EP1812030A4 (en)	2009-01-14	Anti-angiogenic peptides and methods of use thereof
EP1786451A4 (en)	2009-07-22	Anti-angiogenic peptides and methods of use thereof
PL2099796T3 (en)	2011-10-31	Aza-indolyl compounds and methods of use
IL190217A0 (en)	2008-11-03	Combination of rosiglitazone and donepezil for improvement of cognitive function
IL185309A0 (en)	2008-02-09	Isoqunoline compounds and methods of use thereof
IL182494A0 (en)	2007-09-20	Non-peptide bradykinin antagonists and pharmaceutical composition therefrom
IL185308A0 (en)	2008-02-09	Replikin peptides and uses thereof
EP1976864A4 (en)	2010-09-01	Novel peptide and use thereof
IL185223A0 (en)	2008-06-05	Compounds and uses thereof
PL1763520T3 (en)	2009-06-30	Use of trisubstituted benzopyranones
PT2380573E (en)	2015-06-11	Eslicarbazepine acetate and methods of use
IS2463B (en)	2008-11-15	Substitution of diketopiperazine and its use as oxytocin antagonists
GB0505975D0 (en)	2005-04-27	Novel use of peptide
DK2392335T3 (en)	2015-06-29	Use of 24-norUDCA
PL379702A1 (en)	2006-11-13	Benzamide derivatives as oxytocin agonists and vasopressin antagonists
ZA200707090B (en)	2008-10-29	2-(4-oxo-4H-quinazolin-3-yl) acetamides and their use as vasopressin V3 antagonists
ZA200804681B (en)	2009-11-25	Inhibitors of C-Met and uses thereof
PL376607A1 (en)	2007-02-19	Application of antagonists oxytocin and/or vasopressin
ZA200802439B (en)	2009-04-29	Combination of rosiglitazone and donepezil for improvement of cognitive function
IL185548A0 (en)	2008-08-07	Medical uses of 39-desmethoxyrapamycin and analogues thereof
ZA200805245B (en)	2009-11-25	Combination of AXD2171 and pemetrexed
ZA200804378B (en)	2009-10-28	Iminopropene compound and use thereof